Forbion
Investor profile
Venture capital
Forbion has backed 31 European tech companies across 34 funding rounds between 2011 and 2026, joining rounds totalling €2.7B. Most active in Healthtech and Agritech. Data as of Nov 2026.
Also recorded as: Forbion Capital Partners · Forbion Ventures
Deals
34
distinct rounds
Companies
31
backed
Active span
2011–2026
16 yrs
Total round €
€2.7B
sum of rounds joined
Deals by year
distinct rounds / yearForbion — deals by year — interactive chart.
Data table
| Forbion — deals by year | |
|---|---|
| 2011 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 7 |
| 2026 | 2 |
Top sectors
by dealsForbion — top sectors — interactive chart.
Data table
| Forbion — top sectors | |
|---|---|
| Healthtech | 29 |
| Agritech | 2 |
| Cleantech | 2 |
| Foodtech | 1 |
Stages
by dealsForbion — stages — interactive chart.
Data table
| Forbion — stages | |
|---|---|
| Series A | 13 |
| Series B | 10 |
| Series C | 6 |
| Other | 4 |
| Seed | 1 |
Countries
by dealsForbion — countries — interactive chart.
Data table
| Forbion — countries | |
|---|---|
| UK | 11 |
| Germany | 8 |
| Switzerland | 6 |
| Netherlands | 4 |
| Spain | 2 |
| Belgium | 1 |
| Denmark | 1 |
| Ireland | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Jeito Capital5
- Novo Holdings5
- Sofinnova Partners5
- Novartis Venture Fund4
- BioGeneration Ventures3
- Gilde Healthcare3
- Polaris Partners3
- Wellington Partners3
- Atlas Venture2
- Boehringer Ingelheim Venture Fund2
- Brandon Capital2
- Corteva2
- Cowen Healthcare Investments2
- Edmond de Rothschild Venture Capital2
- Forbion Growth2
- GIMV2
- High-Tech Gründerfonds (HTGF)2
- Invus2
- NRW.BANK2
- Panakès Partners2
- Pontifax Funds2
- RA Capital Management2
- Sunstone Capital2
- Syncona Partners2
- UPMC Enterprises2
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Bicycle Therapeutics | UK | 1 | €512M |
| Verdiva Bio | UK | 1 | €399M |
| OMass Therapeutics | UK | 1 | €273M |
| Azafaros | Netherlands | 2 | €157M |
| Noema Pharma | Switzerland | 2 | €134M |
| Anaveon | Switzerland | 1 | €105M |
| Tropic | UK | 1 | €91M |
| Orbis Medicines | Denmark | 1 | €90M |
| Citryll | Netherlands | 1 | €85M |
| Precirix | Belgium | 1 | €80M |
| Complement Therapeutics | Germany | 1 | €72M |
| Pheon Therapeutics | UK | 1 | €71M |
| Northsea Therapeutics | Netherlands | 1 | €71M |
| Mosanna Therapeutics | Switzerland | 1 | €70M |
| F2G | UK | 1 | €69M |
| Numab | Switzerland | 1 | €53M |
| Vectivbio | Switzerland | 1 | €52M |
| CatalYm | Germany | 1 | €50M |
| Inflazome | Ireland | 1 | €40M |
| Sanifit | Spain | 1 | €37M |
| CellNovo | UK | 1 | €35M |
| Enterprise Therapeutics | UK | 1 | €30M |
| Replimune | UK | 1 | €27M |
| Allecra Therapeutics | Germany | 1 | €22M |
| Rigontec | Germany | 2 | €18M |
| Eeden | Germany | 1 | €18M |
| Novameat | Spain | 1 | €17M |
| PACT | UK | 1 | €17M |
| OMEICOS | Germany | 1 | €17M |
| SOLASTA Bio | UK | 1 | €13M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Bicycle Therapeutics | Other | €512M | 2024-05 |
| Verdiva Bio | Series A | €399M | 2025-01 |
| Azafaros | Series B | €132M | 2025-05 |
| Anaveon | Series B | €105M | 2021-12 |
| Noema Pharma | Series B | €105M | 2023-03 |
| Tropic | Series C | €91M | 2026-03 |
| Orbis Medicines | Series A | €90M | 2025-01 |
| Citryll | Series B | €85M | 2024-12 |
| Precirix | Series B | €80M | 2022-03 |
| Complement Therapeutics | Series A | €72M | 2023-04 |